Pfizer vaccine offers protection after the first dose: FDA

The Food and Drug Administration said data from Pfizer shows its vaccine reduced the risk of COVID-19 after the first dose and was "consistent" with regulators' recommendations for emergency approval, signaling a promising start to a review that will unfold this week and likely kickstart the U.S. immunization campaign.

Regulators ...